{"id":15708,"date":"2023-02-02T02:11:00","date_gmt":"2023-02-02T02:11:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4002600_AE02600_0"},"modified":"2023-02-02T02:11:00","modified_gmt":"2023-02-02T02:11:00","slug":"accelerating-energy-efficiency-adoption-deep-tech-startup-krosslinker-develops-a-cost-effective-aerogel-insulation","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=15708","title":{"rendered":"Accelerating Energy Efficiency Adoption, Deep-tech Startup KrossLinker Develops a Cost-effective Aerogel Insulation"},"content":{"rendered":"\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SINGAPORE<\/span>, Feb. 2, 2023<\/span> \/PRNewswire\/ — KrossLinker<\/b>, an energy-efficiency-focused deep-tech advanced material startup, is designing and developing the world’s most insulating nanomaterial, aerogel, that is low-cost, environmentally friendly, and scalable.<\/p>\n

Efficient and sustainable solutions for the most demanding insulation applications<\/b><\/p>\n

KrossLinker’s first aerogel product, Cryar\u00ae Aerogel Board, targets the cold-chain industry, where a positive market growth trend<\/a> is expected. But this industry faces a USD$ 35 billion<\/span> revenue loss annually<\/a> due to temperature excursions. A 2020 report<\/a> indicated that packaging costs account for around 30% of the total spending of pharmaceutical cold chain companies. KrossLinker’s Cryar\u00ae provides an effective solution to combat this billion-dollar loss.<\/p>\n

Cryar\u00ae is a first-of-its-kind water-based, eco-friendly Si-Aerogel composite board developed through an energy-efficient process. The nano-porous structure of silica aerogel imparts Cryar\u00ae with the best-in-class, and reliable thermal insulation performance, making it a safe, compact, and sustainable solution to transport valuable pharma products, including drugs, vaccines, clinical trial samples, and more.<\/p>\n

KrossLinker has collaborated with several specialty packaging, logistic companies, and hospitals to commercialize and accelerate the adoption of Cryar\u00ae aerogel shippers. It has been building strategic partnerships with market leaders to co-develop aerogel products to tackle similar problems in vertical markets, such as e-mobility and energy infrastructure.<\/p>\n

The role of ADB Ventures <\/b><\/p>\n

ADB Ventures has remained one of KrossLinker’s key investors and partners since 2022. Qiyong Cao<\/span>, the Senior Investment Specialist at ADB Ventures, talked about KrossLinker’s potential: “KrossLinker’s proprietary patented aerogel platform technology (ASPIRE\u00ae) addresses the lengthy research and development, high capital expenditure, and intensive energy consumption of traditional aerogel manufacturing processes. It allows for a significant disruptive impact, enabling affordable access to one of the best insulation materials for mainstream markets and unlocking tremendous market opportunities.”<\/p>\n

What makes KrossLinker unique? <\/b><\/p>\n

Numerous things make KrossLinker stand out from the crowd. Recognized for Cryar\u00ae’s best-in-class insulation performance, long-term stability of properties, non-toxic, water-based, lightweight, and reusable, KrossLinker is also known for being:<\/p>\n